Targeting the Putamen with Gene Therapy Leads to Sustained Improvements in Motor and Non-Motor Functions in Children with AADC Deficiency SOUTH PLAINFIELD, N.J., Aug. 23, 2021 – PTC Therapeutics, Inc.
Stopping an already initiated but inappropriate response is critical to adaptive behavior in humans, and a brain circuit involving the inferior frontal cortex, the presupplementary motor area, and the ...
Basal Ganglia (Putamen) Intracerebral Hemorrhage: Axial CT scans. Note the large intracerebral hemorrhage originating in the area of the basal ganglia on the left. The basal ganglia is a common ...
SOUTH PLAINFIELD, N.J., Aug. 23, 2021 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the publication of a manuscript, “Gene Therapy in the Putamen for Curing AADC Deficiency and ...